CenterPointLock Stoma Cap
CenterPointLock Sterile Drainable Kits
CenterPointLock Non-Sterile Urostomy Kits
CenterPointLock Pre-Sized Convex FlexWear Skin Barrier
Medicine Products:(Date:12/3/2008)...OS ANGELES, Dec. 3 ,Bugaboo Intern... of Bugaboo,Americas. Boiler has been the marketi... 5 years. "Kari Boiler has the Bugaboo DNA and she...yer with the vision that Bugaboo Americas,needs i...oo International. , (Photo: http://www.new...
(Date:12/3/2008)...-USNewswire/ -- The American Society of Hematology...on of blood specialists, expects more than 20,000 ...mber 6-9, 2008, at the Moscone Center in San Franc...earch and treatments for blood disorders. In honor...lso be several special programs including a unique...
(Date:12/3/2008)...swire/ -- MedQuist Inc. (Nasdaq: MEDQ ), the lar...TSO) in the world, is pleased to announce the posi..., , Resolution of the DOJ Investigation ,...eived an administrative HIPAA subpoena for documen...DOJ") on December 17, 2004. The subpoena sought in...
(Date:12/3/2008)...ries were free of tumor recurrence an average of 1...n., Dec. 3 A new Mayo C...omas survived longest when they underwent aggressi...or. If safely removing the entire tumor was not po...n surgery was followed by radiation therapy. This ...
Breaking Medicine News(10 mins):Health News:Kari Boiler Named President of Bugaboo Americas 2Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 2Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 3Health News:50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3...tored surveillance for patients with colon and rec... cancer recurrence // compared to less aggressive ...itals. Researchers have found that an intensified ...tate increased the chances of early diagnosis of c...
...titute for Biotechnology are finding out the mecha...tain mice which had the capacity to resist bacteri...ce model to find out new therapeutic pathways whic...ections. Bacterial infections are the most common...
...oportions not only in the animal world but human w... wanting to visit // countries with bird flu like ...from doctors. At the moment the unanimous voice is... is an animal disease and not a problem for humans...
... from Hong Kong from buying poultry from southern ...consumed during the // ar New Year holiday. One se...g residents would ask vendors to kill and pluck th...through the customs. Hong Kong health authorities...
Other Medicine News:(Date:12/3/2008)...atment alleviates long-term anemia and organ damag... , , MEMPHIS, Tenn., Dec. 3 /PRNewswire-US...rrective gene into mouse blood cells, scientists a...iated sickle cell disease pathology. In their stud...howed essentially no difference from normal mice. ...
(Date:12/3/2008)..., Dec. 3 Isis Pharmaceut...t OncoGenex Pharmaceuticals, Inc.,provided positi...ical trial of,OGX-011 in combination with docetax... docetaxel and prednisone alone ("the control arm"... resistant prostate cancer. The current 10.6,mon...
(Date:12/2/2008)... Breast-specific gamma i...ncers not found on mammograms or by,clinical exam...al meeting of,the Radiological Society of North A...t difficult to detect breast cancer-invasive,lobu....D., professor of,radiology and director of the B...
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Leaders in Pathology Meet in Chicago 3A Sept 30 Oct 3 2007 2070 1Leaders in Pathology Meet in Chicago 3A Sept 30 Oct 3 2007 2070 2RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers 2066 1RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers 2066 2RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers 2066 3SLIM Search Inc Sponsors Next Generation Sequencing Conference for the Biomedical Market 844 1SLIM Search Inc Sponsors Next Generation Sequencing Conference for the Biomedical Market 844 2SLIM Search Inc Sponsors Next Generation Sequencing Conference for the Biomedical Market 844 3SLIM Search Inc Sponsors Next Generation Sequencing Conference for the Biomedical Market 844 4Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference 840 1Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference 840 2Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference 840 3...ENEVA, April 20, 2007 /PRNewswire/ -- Addex Pharma...n of a Phase IIa proof of,concept trial with its l...he study achieved its primary objective, the absen...al significance, and,also showed trends towards im...igraine pain at other time points. ADX10059 has,al...
...ATTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Scie...results of its Phase III,AIR-CF2 study evaluating ... patients with cystic fibrosis (CF) who have,pulmo...e study, a,28-day treatment course of aztreonam ly...nhaled or intravenous (IV) antibiotics versus,plac...
Other Medicine Technology:Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7